Biosimilars, Brain Myths, Orphan Drugs, and Ebola
- Author
- Stanford Law School, Center for Law and the Biosciences
- Published
- Tue 21 Oct 2014
- Episode Link
- https://talks.stanford.edu/video/law/clb/podcast/clb_podcast_september_2014.mp3
Hank Greely, Patti Zettler, Dmitry Karshtedt, and Stephanie Bair discuss new developments related to the Biosimilars Act and FDA's orphan drug program, the policy implications of brain myths, and the current Ebola crisis.
